BioSpace News Archive

Biotech Beach

To Provide Timely, Relevant Information on the Global Opioid Epidemic, UC San Diego Extension Will Offer Fundamentals of Opiate Addiction Course in January 2019

Limited-availability online class syllabus will be geared to parents as well as front-line social services and educational providers

December 3, 2018
·
3 min read
Business

BioMatrix Specialty Pharmacy Partners With The National Hemophilia Foundation And Audaire Health To Improve Care For Patients With Bleeding Disorders

Innovative Digital Platform Increases Transparency and Accountability for Patients and Providers

December 3, 2018
·
4 min read
FDA

Notal Vision Announces FDA Grants Breakthrough Device Designation for Pioneering Patient-Operated Home Optical Coherence Tomography (OCT) System

First-of-its-kind artificial intelligence-enabled technology for monitoring exudative age-related macular degeneration (AMD)

December 3, 2018
·
4 min read
Pharm Country

Physicians’ Education Resource® to Host Live Tumor Board: Real-World Evidence to Inform Treatment and Management of ER+ Metastatic Breast Cancer

The live webcast will be accompanied by online enduring activities

December 3, 2018
·
3 min read
Business

Caregiver, Inc. Adds Brian Estler as Special Olympics Event Coordinator

Mark Lashley, president and CEO of Caregiver, Inc., has hired Brian Estler to coordinate efforts around Special Olympics involvement for Caregiver clients, initially in North Texas.

December 3, 2018
·
2 min read
Job Trends

PMI® at 59.3%; November Manufacturing ISM® Report On Business®

New Orders, Production, and Employment Growing

December 3, 2018
·
27 min read
Drug Development

Syndax Pharmaceuticals Announces Presentation of Preclinical Data from Menin-MLL Program at the 60th American Society of Hematology Annual Meeting

Preclinical data provide further support for the clinical application of Company’s Menin-MLL program in acute leukemias

December 3, 2018
·
6 min read
Drug Development

Comprehensive Analyses from Pivotal Phase 3 QuANTUM-R Study Demonstrate Consistent Overall Survival Benefit of Daiichi Sankyo’s FLT3 Inhibitor Quizartinib in Patients with Relapsed/Refractory FLT3-ITD AML

Quizartinib is the first FLT3 inhibitor to demonstrate a survival benefit in a randomized phase 3 study in patients with FLT3-ITD AML, which was refractory or relapsed within six months of first remission, a very aggressive subtype of the disease associated with poor prognosis

December 3, 2018
·
8 min read
Pharm Country

Olympus 3D/FlexDex Named 2018 Excellence in Surgical Products Award Winner

Olympus recognized by surgical health professionals’ reader feedback for exceptional OR equipment

December 3, 2018
·
4 min read
Job Trends

Boys & Girls Clubs In Kansas Awarded New Grants By Amerigroup Foundation

Grants provide $5,000 to each Club to improve health & wellness factors among Kansas youth to create healthier future generations

December 3, 2018
·
4 min read